Friday - November 28, 2025

“I’m A Miracle” – The Powerful True Story of Healing, Faith, and God’s Unfailing Grace By Minister Leretha H. Wyatt

Greensboro, NC – From life-threatening diagnoses to divine deliverance, Minister Leretha H. Wyatt’s new book, I’m A Miracle, is a moving and faith-filled testimony of God’s healing power and faithfulness through every battle. Diagnosed with breast cancer not once, but … Continue reading

IgG4-related disease Market Size was USD 170 million in 2024, estimates DelveInsight | Zenas BioPharma, Horizon Therapeutics, Sanofi, Roche, AbbVie, Gilead Sciences, Takeda

IgG4-related disease Market The IgG4-Related Disease market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage IgG4-Related Disease pipeline products will significantly revolutionize the IgG4-Related Disease market dynamics. The … Continue reading

Colorectal Cancer Clinical Trial Landscape Expands With 200+ Emerging Therapies, Reveals DelveInsight

Colorectal Cancer Clinical Trial Colorectal Cancer companies are Nektar Therapeutics, ALX Oncology Inc., Processa Pharmaceuticals, Guojian Pharmaceutical, Gritstone Bio, Inc., Daiichi Sankyo, Novartis Pharmaceuticals, Shanghai Henlius Biotech, Sumitomo Pharma Oncology, Purple Biotech Ltd., Amgen, Mirati Therapeutics, Plus Therapeutics, Sparrow Pharmaceuticals, … Continue reading

Triple Negative Breast Cancer Clinical Trial Landscape Expands With 170+ Emerging Therapies, Reveals DelveInsight

Triple Negative Breast Cancer Clinical Trial Emerging TNBC therapies include TECENTRIQ (Hoffmann-La Roche), IPI-549 (Infinity Pharmaceuticals), Leronlimab (CytoDyn), MDNA11 (Medicenna Therapeutics), VIP236 (Vincerx Pharma), and CFI-400945 (Treadwell Therapeutics) – are poised to significantly influence market expansion and transform the overall … Continue reading

Obesity Clinical Trial Landscape Expands With 100+ Emerging Therapies, Reveals DelveInsight

Obesity Clinical Trial Obesity Companies are Pfizer, Biolingus, Regor Pharmaceuticals, Zealand Pharma, Sirnaomics, Innovent Biologics, PegBio, NodThera Limited, Sciwind Biosciences, Boehringer Ingelheim, Clearmind Medicine, Sparrow Pharmaceuticals, Genexine, TransThera, Fractyl Health, Shionogi, and others. (Albany, USA) According to DelveInsight’s analysis, over … Continue reading

FSGS Market Analysis and Forecast 2024-2034: Clinical Trials, Epidemiology, Medications, and Leading Companies by DelveInsight

Focal Segmental Glomerulosclerosis Market Focal Segmental Glomerulosclerosis Companies are Travere Therapeutics, Dimerix, Goldfinch Bio, Vertex Pharmaceuticals, GlaxoSmithKline, Dimerix Bioscience Pty Ltd, ChemoCentryx, AstraZeneca, Genentech, Inc., Sanofi, Mallinckrodt ARD LLC, ACELYRIN Inc., Kyowa Kirin Co., Ltd., Bristol-Myers Squibb, and others. Focal … Continue reading